What is the Lupin PE ratio today?
Lupin's PE ratio is 16.5 at the 29 October 2026 close (₹1,989.90 a share): a market capitalisation of ₹90,988 crore divided by consolidated net profit attributable to shareholders of ₹5,529 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit attributable to shareholders (₹5,333 crore) it is 17.1.
What is the Lupin PB ratio (price to book value)?
Lupin's price-to-book (PB) ratio is 4.05 at the 29 October 2026 close: a market capitalisation of ₹90,988 crore divided by shareholders' equity (book value) of ₹22,448 crore on 31 March 2026. That is a book value of ₹490.94 per share against a share price of ₹1,989.90.
What is the Lupin net worth?
Lupin's net worth — shareholders' equity in its consolidated balance sheet — was ₹22,448 crore on 31 March 2026, up 30.5% from ₹17,204 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹90,988 crore at the 29 October 2026 close.
What is the Lupin market cap?
Lupin's market capitalisation was ₹90,988 crore at the 29 October 2026 close: 45.73 crore shares at ₹1,989.90 each.
What is the Lupin EPS?
Lupin's basic earnings per share (EPS) were ₹116.75 in FY26, against ₹71.95 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹121.01.
What is the Lupin dividend in 2026 and its record date?
In 2026, Lupin has declared one dividend: ₹18 with record date 17 July 2026.
Is Lupin debt free?
No. Lupin had borrowings of ₹5,910 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.26. Its cash and current investments were ₹9,230 crore, so it held net cash of ₹3,320 crore.
What is the Lupin debt to equity ratio?
Lupin's debt-to-equity ratio was 0.26 on 31 March 2026: borrowings of ₹5,910 crore against total equity of ₹22,513 crore. A year earlier, on 31 March 2025, it was 0.29.
What is the Lupin dividend yield?
Lupin's dividend yield is 0.90% at the 29 October 2026 close: dividends of ₹18 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹1,989.90. They were ₹18 on 17 July 2026.
What is the Lupin ROE and ROCE?
In FY26, Lupin's return on equity (ROE) was 26.9% and its return on capital employed (ROCE) was 32.4%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 20.8% and ROCE 23.0%.
What is the Lupin book value per share?
Lupin's book value per share was ₹490.94 on 31 March 2026: shareholders' equity of ₹22,448 crore divided by the 45.73 crore shares in issue, up 30.3% from ₹376.77 a year earlier. The share price at the 29 October 2026 close was ₹1,989.90.
What is the Lupin shareholding pattern?
On 30 September 2026, Lupin's shares were held by promoters 46.84%, foreign portfolio investors (FII/FPI) 23.28%, domestic institutions (DII) 23.78% (including mutual funds at 14.58%) and retail and other non-institutional investors 6.09%. Over the year, FII holding was up 2.79 percentage points from 20.49% and DII holding was down 2.77 percentage points from 26.55%.
What is the Lupin promoter holding?
Promoters held 46.84% of Lupin on 30 September 2026, down 0.01 percentage points from 46.85% the previous quarter and down 0.06 percentage points from 46.90% a year earlier, according to the shareholding pattern filed with NSE.
What is the Lupin free cash flow?
In FY26, Lupin generated ₹7,546 crore of cash from operations and spent ₹2,055 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹5,491 crore. In FY25 it was −₹1,252 crore.
What are the Lupin latest quarterly results?
Lupin's latest results are for Q1 FY27 (April–June 2026), filed on 6 August 2026: consolidated net profit attributable to shareholders ₹1,415 crore, up 16.1% from ₹1,219 crore in Q1 FY26; revenue from operations ₹8,277 crore, up 32.0% year on year.
What is the Lupin revenue and profit in FY26?
In FY26 (April 2025–March 2026), Lupin's consolidated net profit attributable to shareholders was ₹5,333 crore, up 62.5% from ₹3,282 crore in FY25, on revenue from operations of ₹27,958 crore (up 23.1%). Over three years, from FY23, net profit was null.
When are the Lupin next results?
Lupin will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, the date of the board meeting it has notified to the exchanges.
How does the Lupin PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Lupin's PE ratio is 17.1, the lowest of the four: Sun Pharma 36.8, Cipla 28.3 and Dr Reddy's 26.8, a peer average of 30.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
How does Lupin compare with its peers?
On FY26 consolidated figures, against Sun Pharma, Cipla and Dr Reddy's: Lupin's operating margin of 26.6% is the highest of the four (Sun Pharma 25.3%, Cipla 16.6%, Dr Reddy's 13.0%; peer average 18.3%); its return on equity of 26.9% is the highest of the four (Sun Pharma 14.7%, Cipla 11.8%, Dr Reddy's 11.8%; peer average 12.8%); its revenue growth over three years of 18.9% a year is the highest of the four (Sun Pharma 10.0% a year, Cipla 7.4% a year, Dr Reddy's 11.0% a year; peer average 9.5% a year).
Lupin vs Sun Pharma: how do they compare?
In FY26, Lupin earned net profit attributable to shareholders of ₹5,333 crore on revenue of ₹27,958 crore, against ₹11,479 crore on ₹58,462 crore for Sun Pharma. Lupin's operating margin was 26.6% (Sun Pharma 25.3%) and its return on equity 26.9% (Sun Pharma 14.7%). At the 29 October 2026 close, Lupin's market capitalisation was ₹90,988 crore against ₹4,22,517 crore for Sun Pharma, and its PE ratio on FY26 profit 17.1 against 36.8.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
